362 related articles for article (PubMed ID: 11181368)
21. Cefpodoxime proxetil, its in vitro antibacterial activity, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal activity with serum complement and mouse-cultured macrophages.
Yokota T; Suzuki E; Arai K
Drugs Exp Clin Res; 1988; 14(8):495-500. PubMed ID: 3073932
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus.
Sumita Y; Nouda H; Kanazawa K; Fukasawa M
Antimicrob Agents Chemother; 1995 Apr; 39(4):910-6. PubMed ID: 7785994
[TBL] [Abstract][Full Text] [Related]
24. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
Yoshida T; Tateda E; Hiramatsu K; Yokota T
Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
[TBL] [Abstract][Full Text] [Related]
25. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
[TBL] [Abstract][Full Text] [Related]
27. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains.
Sakoulas G; Gold HS; Venkataraman L; DeGirolami PC; Eliopoulos GM; Qian Q
J Clin Microbiol; 2001 Nov; 39(11):3946-51. PubMed ID: 11682512
[TBL] [Abstract][Full Text] [Related]
28. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
Limbert M; Isert D; Klesel N; Markus A; Seeger K; Seibert G; Schrinner E
Antimicrob Agents Chemother; 1991 Jan; 35(1):14-9. PubMed ID: 2014969
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
Utsui Y; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
[TBL] [Abstract][Full Text] [Related]
30. In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria.
Chamberland S; Blais J; Hoang M; Dinh C; Cotter D; Bond E; Gannon C; Park C; Malouin F; Dudley MN
Antimicrob Agents Chemother; 2001 May; 45(5):1422-30. PubMed ID: 11302805
[TBL] [Abstract][Full Text] [Related]
31. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H
Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
[TBL] [Abstract][Full Text] [Related]
32. In vitro antibacterial activity of KP-736, a new cephem antibiotic.
Maejima T; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1991 Jan; 35(1):104-10. PubMed ID: 2014964
[TBL] [Abstract][Full Text] [Related]
33. In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
Nagano R; Shibata K; Adachi Y; Imamura H; Hashizume T; Morishima H
Antimicrob Agents Chemother; 2000 Mar; 44(3):489-95. PubMed ID: 10681308
[TBL] [Abstract][Full Text] [Related]
34. Mode of action of the dual-action cephalosporin Ro 23-9424.
Georgopapadakou NH; Bertasso A; Chan KK; Chapman JS; Cleeland R; Cummings LM; Dix BA; Keith DD
Antimicrob Agents Chemother; 1989 Jul; 33(7):1067-71. PubMed ID: 2675755
[TBL] [Abstract][Full Text] [Related]
35. The antimicrobial activity of cefpirome, a new cephalosporin.
Wise R; Andrews JM; Cross C; Piddock LJ
J Antimicrob Chemother; 1985 Apr; 15(4):449-56. PubMed ID: 3874198
[TBL] [Abstract][Full Text] [Related]
36. Comparative in vitro activity of cefepime against nosocomial isolates.
Sofianou D; Tsoulfa S; Kontodimou L; Polydorou F; Malaka E
J Chemother; 1997 Oct; 9(5):341-6. PubMed ID: 9373789
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.
Une T; Otani T; Sato M; Ikeuchi T; Osada Y; Ogawa H; Sato K; Mitsuhashi S
Antimicrob Agents Chemother; 1985 Apr; 27(4):473-8. PubMed ID: 3873898
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo antibacterial activities of OPC-20011, a novel parenteral broad-spectrum 2-oxaisocephem antibiotic.
Matsumoto M; Tamaoka H; Ishikawa H; Kikuchi M
Antimicrob Agents Chemother; 1998 Nov; 42(11):2943-9. PubMed ID: 9797230
[TBL] [Abstract][Full Text] [Related]
39. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.
Hanaki H; Akagi H; Masaru Y; Otani T; Hyodo A; Hiramatsu K
Antimicrob Agents Chemother; 1995 May; 39(5):1120-6. PubMed ID: 7625799
[TBL] [Abstract][Full Text] [Related]
40. TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties.
Ishikawa T; Matsunaga N; Tawada H; Kuroda N; Nakayama Y; Ishibashi Y; Tomimoto M; Ikeda Y; Tagawa Y; Iizawa Y; Okonogi K; Hashiguchi S; Miyake A
Bioorg Med Chem; 2003 May; 11(11):2427-37. PubMed ID: 12735989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
